Cerebrolysin and Recovery after Stroke (CARS): A randomized, placebo-controlled, double-blind, multicenter, phase ii clinical study

被引：0
|
作者：
Muresanu, D. [1 ]
Heiss, W. D. [2 ]
Bajenaru, O. [3 ]
Popescu, C. D. [4 ]
Vester, J. [5 ]
Guekht, A. [6 ]
机构：
[1] Univ Med & Pharm Iuliu Hatieganu, Neurosci, Cluj Napoca, Romania
[2] Max Planck Inst Neurol Res, Neurol, D-50931 Cologne, Germany
[3] Carol Davila Univ Med & Pharm, Neurol, Bucharest, Romania
[4] Carol Davila Univ Med & Pharm, Neurol, Iasi, Romania
[5] IDV Data Anal & Study Planning, Biometry & Clin Res, Krailing, Germany
[6] Russian State Med Univ Moscow City Hosp, Neurol & Neurosurg, Moscow, Russia
来源：
INTERNATIONAL JOURNAL OF STROKE | 2015年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ESOC-1155
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [41] Chinese Herb Astragalus membranaceus Enhances Recovery of Hemorrhagic Stroke: Double-Blind, Placebo-Controlled, Randomized Study
    Chen, Chun-Chung
    Lee, Han-Chung
    Chang, Ju-Hsin
    Chen, Shuang-Shuang
    Li, Tsai-Chung
    Tsai, Chang-Hai
    Cho, Der-Yang
    Hsieh, Ching-Liang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [42] Cerebrolysin improves clinical outcome in moderate to moderately severe vascular dementia: results from a randomized, double-blind, placebo-controlled, multicenter trial
    Guekht, A.
    Doppler, E.
    Moessler, H.
    Gusev, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 391 - 391
  • [43] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
    M. Panisset
    S. Gauthier
    H. Moessler
    M. Windisch
    Journal of Neural Transmission, 2002, 109 : 1089 - 1104
  • [44] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
    Panisset, M
    Gauthier, S
    Moessler, H
    Windisch, M
    JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (7-8) : 1089 - 1104
  • [45] Cerebrolysin in Alzheimer's disease: A Randomized, Double-blind, Placebo-controlled Trial with a Neurotrophic Agent
    Ruther, E.
    Kasper, S.
    Moessler, H.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 57 - 58
  • [46] κ-opioid system in uremic pruritus:: Multicenter, randomized, double-blind, placebo-controlled clinical studies
    Wikström, B
    Gellert, R
    Ladefoged, SD
    Danda, Y
    Akai, M
    Ide, K
    Ogasawara, M
    Kawashima, Y
    Ueno, K
    Mori, A
    Ueno, Y
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (12): : 3742 - 3747
  • [47] Apremilast For The Treatment Of Behcet's Syndrome: A Phase II Randomized, Placebo-Controlled, Double-Blind Study
    Hatemi, Gulen
    Melikoglu, Melike
    Tunc, Recep
    Korkmaz, Cengiz
    Ozturk, Banu Turgut
    Mat, Cem
    Merkel, Peter A.
    Calamia, Kenneth
    Liu, Ziqi
    Pineda, Lilia
    Stevens, Randall M.
    Yazici, Hasan
    Yazici, Yusuf
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S322 - S322
  • [48] S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study
    Steiner, TJ
    Ahmed, F
    Findley, LJ
    MacGregor, EA
    Wilkinson, M
    CEPHALALGIA, 1998, 18 (05) : 283 - 286
  • [49] Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
    Hsu, Chiun
    Yang, Tsai-Sheng
    Huo, Teh-Ia
    Hsieh, Ruey-Kuen
    Yu, Chih-Wei
    Hwang, Wei-Shou
    Hsieh, Tsai-Yuan
    Huang, Wen-Tsung
    Chao, Yee
    Meng, Robin
    Cheng, Ann-Lii
    JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1097 - 1103
  • [50] A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer
    Xu, Rui-Hua
    Shen, Lin
    Wang, Keming
    Wu, Gang
    Shi, Chunmei
    Ding, Kefeng
    Lin, Lizhu
    Wang, Jinwan
    Xiong, Jianping
    Wu, Changping
    Li, Jin
    Liu, Yunpeng
    Wang, Dong
    Ba, Yi
    Feng, Jueping
    Bai, Yuxian
    Bi, JingWang
    Ma, Liwen
    Lei, Jian
    Yu, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345